Article Details
Retrieved on: 2021-04-16 18:30:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The first was Roche's Rituxan (rituximab), approved by the U.S. Food and Drug Administration (FDA) in 1997 for patients with non-Hodgkin's ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here